Table 5.
Univariate and multivariate analysis of overall survival in the patients classified into FIGO 2018 stage IIIC2p.
| Variables | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| (No. of patients) | HR | 95% CI | p value | HR | 95% CI | p value |
| Age (continuous) | 0.986 | 0.957–1.017 | 0.959 | 0.909–1.009 | ||
| Histology | ||||||
| SCC (46) | 1 (reference) | 1 (reference) | ||||
| nSCC (30) | 1.017 | 0.790–3.269 | 0.191 | 1.303 | 0.412–4.125 | 0.652 |
| pT classificaion | ||||||
| T1b (21) | 1 (reference) | 1 (reference) | ||||
| T2a (10) | 1.261 | 0.315–5.048 | 0.743 | 0.872 | 0.135–5.615 | 0.885 |
| T2b (45) | 2.344 | 0.946–5.806 | 0.066 | 1.497 | 0.345–6.498 | 0.590 |
| T2a | 1 (reference) | 1 (reference) | ||||
| T2b | 1.859 | 0.556–6.216 | 0.314 | 1.717 | 0.342–8.611 | 0.511 |
| Tumor diameter | ||||||
| ≤ 40 mm (44) | 1 (reference) | 1 (reference) | ||||
| > 40 mm (31) | 2.178 | 1.057–4.488 | 0.035 | 1.881 | 0.541–6.535 | 0.320 |
| Stromal invasion | ||||||
| ≤ 1/2 (7) | 1 (reference) | 1 (reference) | ||||
| > 1/2 (57) | 2.699 | 0.364–19.996 | 0.331 | 0.841 | 0.095–7.479 | 0.877 |
| Ovarian metastasis | ||||||
| Negative/preserved (65) | 1 (reference) | 1 (reference) | ||||
| Positive (11) | 1.447 | 0.554–3.777 | 0.451 | 0.611 | 0.066–5.678 | 0.665 |
| Corpus invasion | ||||||
| Negative (49) | 1 (reference) | 1 (reference) | ||||
| Positive (27) | 1.631 | 0.803–3.314 | 0.176 | 1.394 | 0.441–4.400 | 0.572 |
| Adjuvant therapy | ||||||
| CCRT (26) | 1 (reference) | 1 (reference) | ||||
| CT (34) | 0.875 | 0.337–2.270 | 0.783 | 0.908 | 0.220–3.738 | 0.893 |
| RT (10) | 5.707 | 2.112–15.423 | < 0.001 | 5.694 | 1.346–24.084 | 0.018 |
| None (2) | 10.324 | 1.179–90.391 | 0.035 | 31.191 | 1.509–644.748 | 0.026 |
| CT | 1 (reference) | 1 (reference) | ||||
| RT | 6.526 | 2.506–16.999 | < 0.001 | 6.274 | 1.751–22.485 | 0.018 |
| None | 11.805 | 1.373–101.479 | 0.025 | 34.369 | 2.073–569.752 | 0.014 |
| RT | 1 (reference) | 1 (reference) | ||||
| None | 1.809 | 0.218–14.981 | 0.583 | 5.478 | 0.299–100.284 | 0.252 |
| Peritoneal cytology | ||||||
| Negative (30) | 1 (reference) | |||||
| Positive (9) | 1.452 | 0.555–3.794 | 0.447 | |||
| LVSI | ||||||
| Negative (4) | 1 (reference) | |||||
| Positive (68) | NA | NA | NA | |||
| PLN metastasis | ||||||
| Negative (2) | 1 (reference) | |||||
| Positive (74) | NA | NA | NA | |||
FIGO The International Federation of Gynecology and Obstetrics, HR hazard ratio, CI confidence interval, SCC squamous cell carcinoma, nSCC non-squamous cell carcinoma, PLN pelvic lymph node, LVSI lymphovascular space invasion, CCRT concurrent chemoradiotherapy, CT chemotherapy, RT radiotherapy.